Lexaria executing a triple-pronged strategy in obesity and diabetesSemaglutide recently approved to treat chronic kidney disease KELOWNA, BC / ACCESS Newswire / February 27, 2025 / Lexaria Bioscience ...
People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity.
Ozempic is often hailed as a wonder drug, but like any other medication, it’s not perfect. People have reported mild side ...